Our data shows that heterotypic polyfunctional CD4+ T-cell responses to BA.1 do occur following ancestral SARS-Co2/Alpha/Delta infection (Cohort 1) but are lower than those observed following natural BA.1 infection (Cohort 2), and the latter group mounted robust BA.1 specific T-cell responses. The gene discussed is CD4; the disease is breast angiosarcoma.